These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 16780635

  • 1. First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants.
    Roessner V, Robatzek M, Knapp G, Banaschewski T, Rothenberger A.
    Dev Med Child Neurol; 2006 Jul; 48(7):616-21. PubMed ID: 16780635
    [Abstract] [Full Text] [Related]

  • 2. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
    Varley CK, Vincent J, Varley P, Calderon R.
    Compr Psychiatry; 2001 Jul; 42(3):228-33. PubMed ID: 11349243
    [Abstract] [Full Text] [Related]

  • 3. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.
    Erenberg G.
    Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292
    [Abstract] [Full Text] [Related]

  • 4. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Law SF, Schachar RJ.
    J Am Acad Child Adolesc Psychiatry; 1999 Aug; 38(8):944-51. PubMed ID: 10434485
    [Abstract] [Full Text] [Related]

  • 5. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [Abstract] [Full Text] [Related]

  • 6. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR.
    J Child Fam Nurs; 2000 Sep; 3(1):46-8. PubMed ID: 11022478
    [No Abstract] [Full Text] [Related]

  • 7. Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapy.
    Palumbo D, Spencer T, Lynch J, Co-Chien H, Faraone SV.
    J Child Adolesc Psychopharmacol; 2004 Sep; 14(2):185-94. PubMed ID: 15319016
    [Abstract] [Full Text] [Related]

  • 8. Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study.
    Cubo E, Fernández Jaén A, Moreno C, Anaya B, González M, Kompoliti K.
    Clin Ther; 2008 Jan; 30(1):182-9. PubMed ID: 18343255
    [Abstract] [Full Text] [Related]

  • 9. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL.
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [Abstract] [Full Text] [Related]

  • 10. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B, Sopko MA, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.
    Pringsheim T, Steeves T.
    Cochrane Database Syst Rev; 2011 Apr 13; (4):CD007990. PubMed ID: 21491404
    [Abstract] [Full Text] [Related]

  • 12. Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD.
    Gadow KD, Nolan EE, Sverd J, Sprafkin J, Schneider J.
    J Child Neurol; 2008 Sep 13; 23(9):981-90. PubMed ID: 18474932
    [Abstract] [Full Text] [Related]

  • 13. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV, Wilens TE.
    J Clin Psychiatry; 2007 Sep 13; 68 Suppl 11():15-22. PubMed ID: 18307377
    [Abstract] [Full Text] [Related]

  • 14. Growth deficits in children with attention deficit hyperactivity disorder.
    Spencer T, Biederman J, Wilens T.
    Pediatrics; 1998 Aug 13; 102(2 Pt 3):501-6. PubMed ID: 9685453
    [Abstract] [Full Text] [Related]

  • 15. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
    Nolan EE, Gadow KD, Sprafkin J.
    Pediatrics; 1999 Apr 13; 103(4 Pt 1):730-7. PubMed ID: 10103294
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.
    Poulton A.
    Expert Rev Neurother; 2006 Apr 13; 6(4):551-61. PubMed ID: 16623654
    [Abstract] [Full Text] [Related]

  • 17. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A.
    Pediatrics; 2007 Dec 13; 120(6):e1494-501. PubMed ID: 18055666
    [Abstract] [Full Text] [Related]

  • 18. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J, Pliszka SR.
    J Pediatr; 2008 Mar 13; 152(3):394-9. PubMed ID: 18280848
    [Abstract] [Full Text] [Related]

  • 19. Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder.
    Párraga HC, Párraga MI, Harris DK.
    Int J Psychiatry Med; 2007 Mar 13; 37(4):415-24. PubMed ID: 18441629
    [Abstract] [Full Text] [Related]

  • 20. Children with comorbid attention-deficit-hyperactivity disorder and tic disorder: evidence for additive inhibitory deficits within the motor system.
    Moll GH, Heinrich H, Trott GE, Wirth S, Bock N, Rothenberger A.
    Ann Neurol; 2001 Mar 13; 49(3):393-6. PubMed ID: 11261515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.